Andrew C. Jackson

This profile gathers the share dealings of Andrew C. Jackson across 2 companies, led by Flyte Aviation, Inc. and Calidi Biotherapeutics, Inc. The record holds 12 filings, for trades running from 13 June 2019 to 21 August 2025.

On the open market, the record shows 3 purchases worth €12k and 2 sales worth €20k. Sales outweigh purchases by €8,730. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants. So far in 2025, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €4,244. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 25 August 2025, reports an open-market purchase of €4,305 in Calidi Biotherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.